Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)

Psychiatrist.com

FDA Announces ADHD Drug Recall

Pediatrics February 21st 2024

Psychiatry Advisor

Patient Information Fact Sheet — Symptom Comparison: Attention-Deficit/Hyperactivity Disorder vs Autism Spectrum Disorder

Pediatrics January 23rd 2024

MDLinx

How Diet Affects ADHD Symptoms: Updated Patient Guidance for Clinicians

Internal Medicine January 23rd 2024

Psych Congress Network

Long-term ADHD Med Use May Hike CVD Risk

Cardiology January 10th 2024

Psych Congress Network

Slight Symptom Gains but More Dropouts with Unlicensed Stimulant Doses in ADHD

Psychiatry November 14th 2023

Psychiatrist.com

Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study

Psychiatry October 18th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form